Ablative immunotherapy

Details Ablative immunotherapy Ablative immunotherapy

A - Human Necessities

61

K

A61K 38/17 (2006.01) C07K 16/30 (2006.01) C12N 15/12 (2006.01)

Patent

CA 2669315

A therapeutic composition or a vaccine includes an antigenic composition comprising antigenic material from the tumor and an aliquot of allogeneic cells. The administration of the antigenic composition creates a response that stimulates a delay-type hypersensitivity response to the antigens thereby acting as an adjuvant to the stimulation of systemic anti-rumor or anti- pathogen immunity.

Cette invention se rapporte à une composition thérapeutique ou à un vaccin comprenant une composition antigénique contenant une matière antigénique provenant de la tumeur et un aliquot de cellules allogénique. L'administration de la composition antigénique génère une réponse qui favorise une réponse d'hypersensibilité retardée aux antigènes ce qui agit comme un adjuvant à la stimulation de l'immunité systémique développée à l'encontre de la tumeur ou du pathogène.

Affiliated with

Also associated with

Rating

Ablative immunotherapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Ablative immunotherapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ablative immunotherapy will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1597442